Please ensure Javascript is enabled for purposes of website accessibility

How Much Lower Will Teladoc Stock Go?

By Neil Rozenbaum – Oct 4, 2021 at 11:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The stock is down 44% year over year and 60% since its all-time highs in February.

In this video, I will be talking about Teladoc (TDOC -7.26%) and the recent moves the company has been making. The stock itself isn't doing great at all. Year over year it is down 43%, and since its all-time high, it is down 60%. But a broken stock does not equal a broken company. You can find the full video below. 

Broken stock

As Teladoc has shown us in its latest earnings report, it is still growing while its competitors are failing to keep up. Teladoc Health's organic revenue grew by 41% vs. 69% sequentially. The company reported total revenue of $503 million, up 108.7% year over year and 10.8% quarter over quarter. I compared Teladoc with Amwell a while back and showed that Teladoc is not only growing but also outgrowing its competitors. The main reason I can think of as to why the stock keeps dropping is that the market is afraid the growth story will not continue after the pandemic. 

Execution is key

Teladoc was named as a vendor by Canada Health Infoway for its whole-person care services, which serves approximately 60% of Canada's population. The good news continues Down Under, because Philips and Teladoc have announced a strategic partnership to deliver comprehensive virtual healthcare solutions across hospitals and health systems in Australia and New Zealand.  

And lastly, Teladoc ranked highest among direct-to-consumer providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study. This is the second time Teladoc has taken first place since J.D. Power created this category three years ago.

For the full insights do watch the video below.

*Stock prices used were the closing prices of Oct. 1, 2021. The video was published on Oct. 3, 2021.

Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$27.08 (-7.26%) $-2.12

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.